However, the glycosylated form of luteolin, known as cyranoside or luteolin-7-O-glucoside (Lut7) (PubChem ID 5280637), was reported as a selective JNK3 inhibitor, five times more selective than luteolin [6], which plays a key role in neurodegenerative diseases [7,8,9,10,11], suggesting that patients with neurodegenerative diseases might benefit from a natural or bio-inspired product-based therapy [12,13,14,15,16]. The gene discussed is MAPK10; the disease is neurodegenerative disease.